Get started
Author

Fatima M. Izhaeva

Observed names: F. M. Izhaeva, FM Izhaeva, Fatima M Izhaeva, Ф. М. Ижаева
ORCID: 0000-0002-4110-3941
Observed ORCID: 0000-0002-4110-3941
OpenAlex ID: A5035694656
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
2021 · Denis Y Logunov, Inna V Dolzhikova, et al. · The Lancet · 1,784
PDF
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
2020 · Denis Y Logunov, Inna V Dolzhikova, et al. · The Lancet · 1,071
PDF
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
2021 · Amir I. Tukhvatulin, Inna V. Dolzhikova, et al. · The Lancet Regional Health - Europe · 74
Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant
2021 · IV Dolzhikova, AA Iliukhina, et al. · medRxiv · 22
PDF
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
2023 · Amir I. Tukhvatulin, Inna V. Dolzhikova, et al. · Frontiers in Immunology · 17
PDF
One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow
2021 · Inna V Dolzhikova, Vladimir A Gushchin, et al. · medRxiv · 16
PDF
1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues - Novel Inhibitors of Human Adenovirus Replication
2018 · N. A. Nikitenko, E. S. Gureeva, et al. · Acta Naturae · 10
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
2024 · Inna V. Dolzhikova, Amir I. Tukhvatulin, et al. · Vaccines · 5
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia
2025 · DY Logunov, Dolzhikova, et al. · Frontiers in Immunology · 3
Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents
2026 · Inna V. Shuliakova, Daria M. Grousova, et al. · Frontiers in Immunology · 1
PDF
Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens
2025 · Amir I. Tukhvatulin, Alina S. Dzharullaeva, et al. · Vaccines · 1
PDF
The parameters of long-term humoral immunity induced by a single injection of the Sputnik Light vaccine among non-infected volunteers and those infected with SARS-CoV-2
2025 · F. M. Izhaeva, A. I. Tukhvatulin, et al. · Acta Naturae · 1
PDF
Systematic Approach to Production Technology Development for Therapeutic Proteins (Using Insulin–Glargine as an Example)
2015 · D. A. Gusarov, D. V. Byrikhina, et al. · Pharmaceutical Chemistry Journal · 1
Application of flow cytometry for rapid and precise quantification of Candida albicans cells in samples
2026 · Amir I. Tukhvatulin, Fatima M. Izhaeva, et al. · Journal of microbiology epidemiology immunobiology
PDF
Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates
2025 · Amir I. Tukhvatulin, Ilya V. Gordeychuk, et al. · Frontiers in Immunology
Pharmaceutical Development of Formulation Based on Biopharmaceutical Preparations for Gene Therapy
2019 · T. V. Budylskaya, D. V. Byrikhina, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Создание Промышленной Технологии Биосинтеза Фолликулостимулирующего Гормона В Культуре Клеток Сно
2016 · Д. А. Гусаров, А. И. Государев, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Использование системного подхода для разработки технологии получения терапевтических белков (на примере инсулина-гларгина)
2015 · Д. А. Гусаров, Д. В. Бырихина, et al. · Химико-фармацевтический журнал
PDF
Разработка эффективной промышленной технологии получения активной фармацевтической субстанции рекомбинантного белка NS1, составляющего основу вакцины против вируса клещевого энцефалита
2014 · Fatima M. Izhaeva, П. В. Михайлов, et al. · Биофармацевтический журнал
Показатели гуморального иммунитета после введения «Спутник Лайт» на длительных сроках у неинфицированных и инфицированных SARS-CoV-2 добровольцев
· Ф. М. Ижаева, А. И. Тухватулин, et al. · CyberLeninK (CyberLeninka)
Works count: 20
Citation count: 3,006
H-index: 7
I10-index: 7
Year
Topic
Type